New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
10:48 EDTTCS, ARNA, FOSL, SA, RAXOptions with decreasing implied volatility: ARNA RAX FOSL TCS SA
News For ARNA;RAX;FOSL;TCS;SA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 21, 2015
09:10 EDTARNAArena Pharmaceuticals 21M share Spot Secondary priced at $5.00
Subscribe for More Information
08:51 EDTARNAArena Pharma sells 21M shares to Leucadia's Jefferies and Piper Jaffray
Arena Pharmaceuticals (ARNA) has sold 21M shares of common stock to Jefferies, a subsidiary of Leucadia (LUK) and to Piper Jaffray (PJC) as underwriters for its previously announced public offering. The offering is expected to close on or about January 26. In addition, Arena has granted the underwriters a 30-day option to purchase up to an aggregate of 3M additional shares of common stock. Arena anticipates using the net proceeds from the offering for the clinical and preclinical development of drug candidates, for discovery research for new drug candidates, and for general corporate purposes.
05:58 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
January 20, 2015
18:30 EDTARNAOn The Fly: After Hours Movers
Subscribe for More Information
17:19 EDTARNAArena Pharmaceuticals cash, cash equivalents as of Dec. 31 $163.2M
Subscribe for More Information
16:05 EDTARNAArena Pharmaceuticals files to sell common stock, no amount given
Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering.
09:40 EDTRAXFollow-up: Rackspace upgraded at CLSA
Subscribe for More Information
09:17 EDTRAX, RAXRackspace upgraded to Buy from Outperform at CLSA
Subscribe for More Information
09:10 EDTARNAArena sees Q4 Belviq sales down 35%-45% vs. Q3
Subscribe for More Information
06:57 EDTFOSLMichael Kors relative valuation looks compelling, says Piper Jaffray
Subscribe for More Information
06:41 EDTFOSLFossil downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Fossil to Neutral saying the company's North American growth could slow further while foreign currency is a headwind with a third of its sales coming from Europe. Piper lowered its price target for shares to $104 from $133.
06:08 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
January 16, 2015
06:10 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Stocks with implied volatility below IV index mean; BlackBerry (BBRY) 63, Arena Pharmaceuticals (ARNA) 86 according to iVolatility.
January 15, 2015
06:04 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
January 14, 2015
10:21 EDTARNAOptions with decreasing implied volatility
Subscribe for More Information
06:03 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
January 13, 2015
06:02 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
January 12, 2015
10:24 EDTARNAOptions with increasing implied volatility
Options with increasing implied volatility: TLM GREK ARNA AVP
08:02 EDTARNAArena Pharmaceuticals initiates Phase 2 clinical trial evaluating ralinepag
Arena Pharmaceuticals announced the initiation of patient dosing in a Phase 2 clinical trial of ralinepag, an oral, non-prostanoid prostacyclin receptor agonist intended for the treatment of pulmonary arterial hypertension. This 22-week, randomized, double-blind and placebo-controlled Phase 2 trial will evaluate the hemodynamic and exercise capacity effects, safety and tolerability of ralinepag in up to 60 patients with PAH. During the first nine weeks of the trial, patients will be titrated to their individual tolerance level, and then sustained at this level for the remainder of the trial.
06:14 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use